Iron overload and HFE gene;Surcharges en fer et gene HFE

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 1, 1999, Pages 122-131

  Deugnier, Yves ^a,b   Moirand, Romain ^a   Guyader, Dominique ^a   Jouanolle, Anne Marie ^a   Brissot, Pierre ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Alcoholic liver; Chronic hepatitis C; Dysmetabolic iron overload; Genetic hemochromatosis; Hepatocellular carcinoma; HFE gene mutations; Liver cirrhosis; Porphyria cutanea tarda

Indexed keywords

CERULOPLASMIN BLOOD LEVEL; GENE EXPRESSION; GENETIC ANALYSIS; HEMOCHROMATOSIS; HEPATITIS C; IRON INTAKE; IRON OVERLOAD; LIVER CIRRHOSIS; MASS SCREENING; PORPHYRIA CUTANEA TARDA; REVIEW; ADULT; ALCOHOL LIVER DISEASE; ANEMIA; COMPARATIVE STUDY; FEMALE; GENE; GENETIC MARKER; GENETIC SCREENING; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MUTATION; PORPHYRIA;

ADULT; ANEMIA; CARCINOMA, HEPATOCELLULAR; FEMALE; GENES, MHC CLASS I; GENETIC MARKERS; GENETIC SCREENING; HEMOCHROMATOSIS; HEPATITIS C, CHRONIC; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PORPHYRIAS;

EID: 0032941184     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic hæmochromatosis. Gut 1976;17:332-4.
2. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis: demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med 1977;297:1017-21.
3. Moirand R, Brissot P, Deugnier Y. Prise en charge d'une famille atteinte d'hémochromatose génétique. Gastroenterol Clin Biol 1996;20:B9-14.
4. Feder J, Gnirke A, Thomas W, Tsuchihasbi Z, Ruddy D, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 1996;13:399-408.
5. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino M, Piperno A, et al. Mutation analysis of HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997;60:828-32.
6. Moirand R, Mortaji A, Loréal O, Paillard F, Brissot P, Deugnier Y. Liver iron overload with normal transferrin saturation: a new syndrome. Lancet 1997;349:95-7.
7. Elder G, Worwood M. Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload. Hepatology 1998;27:289-91.
8. Parkkila S, Waheed A, Britton R, Feder J, Tsuchihashi Z, Schatzman R, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 1997;94:2534-5.
9. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, et al. Mutation analysis in hereditary hemochromatosis. Blood Cell Mol Dis 1996;22:187-94.
10. Jouanolle A, Gandon G, Jézéquel P, Blayau M, Campion M, Yaouanq J, et al. Haemochromatosis and HLA-H. Nature Genet 1996;14:251-2.
11. Barton J, Shih W, Sawada-Hirai R, Acton R, Harmon L, Rivers C, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cell Mol Dis 1997;23:135-45.
12. Bell H, Undlien D, Raha-Chowdury R, Berg J, Vartdal F, Raknerud N, et al. Prevalence of the hemochromatosis Cys282Tyr mutation among patients with hemochromatosis and blood donors in Norway. In: Beaumont C, Brissot P, David V, Deugnier Y, eds. International Symposium on Iron in Biology and Medicine 1997, 16-20 June 1997, Saint-Malo (France). 245A.
13. Brissot P, Moirand R, Jouanolle A, Guyader D, Le Gall J, Deugnier Y, et al. A genotypic study of 207 unrelated probands diagnosed as « genetic hemochromatosis » on « classical » phenotypic criteria. J Hepatol (in press).
14. Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M, Hulterantz R. HFE mutations in patients with hereditary haemochromatosis in Sweeden. J Intern Med 1997;243:203-8.
15. Datz C, Lalloz M, Vogel W, Graziadei I, Hackl F, Vautier G, et al. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol 1997;27:773-9.
16. Jeffrey G, Rossi E, Chin C, Basclain K, Olynyk J, Reed W, et al. HLA-H genotyping of a Western Australian genetic haemochromatosis population. In: Beaumont C, Brissot P, David V, Deugnier Y, eds. International Symposium on Iron in Biology and Medicine 1997, 16-20 June 1997, Saint-Malo (France). 248A.
17. Martinez P, Biron C, Blanc F, Masmejean C, Jeanjean P, Michel H, et al. Compound heterozygotes for hemochromatosis gene mutations: may they help to understand the pathophysiology of the disease. Blood Cell Mol Dis 1997;23:269-76.
18. Mura C, Nousbaum J, Verger P, Moalic M, Raguenes O, Mercier A, et al. Phenotype-genotype correlation in haemochromatosis subjects. Hum Genet 1997;101:271-6.
19. Nielsen P, Raha-Chowdhury R, Ahn J, Fischer R, Gruen J, Gabbe E. Allelic association, phenotype, and mutation analysis in genetic haemochromatosis patients from North Germany. In: Beaumont C, Brissot P, David V, Deugnier Y, eds. International Symposium on Iron in Biology and Medicine 1997, 16-20 June 1997, Saint-Malo (France). 252A.
20. Willis G, Jennings B, Goodman E, Fellows I, Wimperis J. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in Eastern England. Blood Cell Mol Dis 1997;23:288-91.
21. Adams P, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114:319-23.
22. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.
23. Merryweather-Clarke A, Pointon J, Shearman J, Robson K. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
24. Roth M, Giraldo P, Hariti G, Poloni E, Sanchez-Mazas A, de Stefano G, et al. Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal. Immunogenetics 1997;46:222-5.
25. Beutler E, Gelbart T. HLA-H mutations in the Ashkenazi Jewish population. Blood Cell Mol Dis 1997;23:95-8.
26. Feder J, Tsuchihashi Z, Irrinki A, Lee V, Mappa F, Morikang E, et al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025-9.
27. Waheed A, Parkkila S, Zhou X, Tomatsu S, Tsuchihashi Z, Feder J, et al. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with bcta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997;94:12384-9.
28. Parkkila S, Waheed A, Britton R, Bacon B, Zhou X, Tomatsu S, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997;94:13198-202.
29. Lebron J, Bennett M, Vaughn D, Chirino A, Snow P, Mintier G, et al. Crystal structure of the hemochromalosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93:111-23.
30. Rothenberg BE, Voland JR. Beta2 knockout mice develop parenchymal iron overload: a putative role for class 1 genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 1996;93:1529-34.
31. Zhou X, Tomatsu S, Fleming R, Parkkila S, Waheed A, Jiang J, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998;95:2492-7.
32. The UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997;41:841-4.
33. Moirand R, Jouanolle A, Deugnier Y, Brissot P, Le Gall J, David V. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 1999;116:372-7.
34. Deugnier Y, Loréal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bio-clinical correlations. Gastroenterology 1992;102:2050-9.
35. Brissot P, Herry D, Verger J, Messner M, Regnouard F, Ferrand B, et al. Assessment of liver iron content in 271 patients: reevaluation of direct and indirect methods. Gastroenterology 1981;80:557-65.
36. Gandon Y, Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhé T, et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994;193:533-8.
37. Basset M, Halliday J, Powell L. Value of iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-9.
38. Summers K, Halliday J, Powell L. Identification of homozygous hemochromatosis subjects by measurement of biochemical hepatic iron index. Hepatology 1990;12:20-5.
39. Brissot P, Deugnier Y. Genetic hemochromatosis. In: Mc Intyre N, Benhamou J, Bircher J, Rizzetto M, Rodés J, eds. Oxford textbook of clinical hepatology. Oxford: Oxford Medical Publications, 1991: 948-58.
40. Adams P, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997;26:162-6.
41. Moirand R, Adams P, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997;127:105-10.
42. Deugnier Y, Rabot A, Guyader D, Moirand R, Turlin B, Boucher E, et al. Serum increase and liver over-expression of carbohydrate 19.9 antigen in patients with genetic hæmochromatosis. Gut 1994:1107-11.
43. Merryweather-Clarke A, Liu Y, Shearman J, Pointon J, Robson K. A rapid non-invasive method for the detection of the haemochromatosis C282Y mutation. Br J Haematol 1997;99:460-3.
44. Deugnier Y, Moirand R, Brissot P. Hémochromatose génétique. Med Ther 1995;1:587-96.
45. Deugnier Y, Charalambous P, Le Quilleuc D, Turlin B, Searle J. Brissot P, et al. Preneoplastic significance of hepatic iron-free-foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993;18:1363-9.
46. Fargion S, Fracanzani A, Piperno A, Braga M, D'Alba R, Ronchi G, et al. Prognostic factors for hepatocellular carcinoma in genetic hemochrornatosis. Hepatology 1994;20:1426-31.
47. Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
48. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendier M, Chaperon J, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:1-9.
49. Deugnier Y, Turlin B, Powell L, Summers K, Moirand R, Fletcher L, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 1993;17:30-4.
50. Bulaj Z, Griffen L, Jorde L, Edwards C, Kushner J. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-805.
51. Powell L, Summers K, Board P, Axelsen E, Webb S, Halliday J. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology 1990;98:1625-32.
52. Roberts A, Whatley S, Morgan R, Worwood M, Elder G. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-3.
53. Adams P, Campion M, Gandon G, LeGall J, David V, Jouanolle A. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical familes. Hepatology 1997;26:986-90.
54. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-8.
55. ANDEM. Evaluation de l'opportunité d'un programme national de dépistage: l'exemple de l'hémochromatose génétique. Paris: Agence Nationale pour le Développement de l'Evaluation Médicale; 1995.
56. Deugnier Y, Turlin B, Le Quilleuc D, Moirand R, Loréal O, Messner M, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997;24:669-75.
57. Deugnier Y, Moirand R, Jouanolle A, Le Gall J, Brissot P, David V. HLA-H mutations in patients with iron overload and normal transferrin saturation. Hepatology 1997;26:199A.
58. Camaschella C, Roetto A, Cicilano M, Pasquero P, Bosio S, Gubetta L. et al. Juvenile and adult hemochromatosis are distinct genetic disorders. Eur J Hum Genet 1997;1997:371-5.
59. Bottomley S. Secondary iron overload disorders. Semin Hematol 1998;35:77-86.
60. Berstein S. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J Lab Clin Med 1987;110:690-705.
61. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospam and retinal degeneration. Neurology 1987;37:761-7.
62. Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995;9:267-72.
63. Logan J, Harveyson K, Wisdom G, Hughes A, Archbold G. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q J Med 1994;87:663-70.
64. Morita H, Ikeda S, Yamamoto K, Monta S, Yoshida K, Nomoto S, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1994;37:646-56.
65. Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, Gitlin J. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol 1997;41:404-7.
66. Gordeuk V, Mukibi J, Haastedt S, Samowitz W, Edwards C, West G, et al. Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med 1992;326:95-100.
67. Moyo V, Mandishona E, Hasstedt S, Gangaidzo I, Gomo Z, Khumalo H, et al. Evidence of genetic transmission in African iron overload. Blood 1998;91:1076-82.
68. Bacon B, Farahvash M, Janney C, Neuschwander-Tetri B. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-9.
69. George D, Goldwurm S, MacDonald G, Cowley L, Walker N, Ward P, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-8.
70. Mendler M, Turlin B, Moirand R, Sapey T, Guyader D, Brissot P, et al. The « dysmetabolic iron overload syndrome »: a concept which unites hepatic iron overload associated with polymetabolic disorders, steatosis and NASH (abstract). Hepatology 1998;28:134A.
71. Deugnier Y, Turlin B, Loréal O. Iron and neoplasia. J Hepatol 1998;28:21-5.
72. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis. Circulation 1997;96:3300-7.
73. Grove J, Daly A, Burt A, Guzail M, Bassendine M, Day C. HLA-H mutations, hepatic iron content and risk of advanced liver disease in alcoholics (abstract). Hepatology 1997;26:275A.
74. Aldersley M, Howdle P, Wyatt J, Robinson P, Markham A. Haemochromatosis gene mutation in liver disease patients. Lancet 1997;349:1025-6.
75. Di Bisceglie A, Axiotis C, Hoofnagle J, Bacon B. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-13.
76. Haque S, Chandra B, Gerber M, Lok A. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 1996;27:1277-81.
77. Boucher E, Bourienne A, Adams P, Turlin B, Brissot P, Deugnier Y Liver iron concentration and distribution in chronic hepatitis C before and after interferon therapy. Gut 1997;41:115-20.
78. Hézode C, Cazeneuve C, Coué O, Pawlotsky J, Zafrani E, Amselem S, et al. Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C. J Hepatol 1998;28:306.
79. Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K, Nonomura A. Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C. Hum Pathol 1995;26:1080-5.
80. Beinker N, Voigt M, Arendse M, Smit J, Stander I, Kirsch R. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 1996;25:633-8.
81. Van Thiel D, Friedlander L, Fagiuoli S, Wright H, Irish W, Gavaler J. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 1994;20:410-5.
82. Olynyk J, Reddy K, Di Bisceglie A, Jeffers L, Parker T, Radick J, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-9.
83. Piperno A, Sampietro M, D'Alba R, Roffi L, Fargion S, Parma S, et al. Iron stores, response to alpha-interferon, and effects of iron depletion in chronic hepatitis C. Liver 1996;16:248-54.
84. Guyader D, Boucher E, Even C, Cottereau J, Bianchi A, Gasser P, et al. Iron reduction therapy is inefficient in patients with chronic hepatitis C who failed to respond to interferon. Am J Gastroenterol (in press).
85. Smith B, Grove I, Guzail M, Day C, Daly A, Burt A, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998;27:1695-9.
86. Gehrke S, Riedel H, Fitscher B, Goeser T, Stremmel W, Kalinowski B. Prevalence of mutations in the hemochromatosis gene HLA-H in patients with chronic hepatitis C: influence on histological activity, iron metabolism, and response to interferon therapy. Hepatology 1997;26:410A.
87. Villeneuve J, Bilodeau M, Lepage R, Côté J, Lefebvre M. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 1997;25:172-7.
88. Ludwig J, Hashimoto E, Porayko M, Moyer T, Baldus W. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112:882-8.
89. Brissot P, Wright T, Ma W, Weisiger R. Efficient clearance of non-transferrin bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J Clin Invest 1985;76:1463-70.
90. Adams P, Bradley C, Frei J. Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis. Hepatology 1994;19:101-5.
91. Farrel F, NGuyen M, Woodley S, Imperial J, Garcia-Kennedy R, Man K, et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology 1994;20:404-10.
92. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsen EM, et al. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst 1985;75:81-4.
93. Deugnier Y, Guyader D, Crantock L, Lopez J, Turlin B, Yaouanq J, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological and pathogenetic study of 54 cases. Gastroenterolgy 1993;104:228-34.
94. Deugnier Y, Turlin B. Other causes of hepatocellular carcinoma. In: Okuda K, Tabor E, editors. Liver cancer. New York: Churchill Livingstone, 1997:97-110.
95. Hann HWL, Kim CY, London WT, Blumberg BS. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer 1989;43:376-9.
96. Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loreal O, Campion JP, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 1995;22:446-50.
97. Willis G, Wimperis S, Lonsdale R, Jennings B. Haemochromatosis gene mutation in hepatocellular cancer. Lancet 1997;350:565-6.
98. Santos M, Clevers H, Marx J. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda. N Engl J Med 1997;336:1327-8.
99. Stuart K, Busfield F, Jazwinska E, Gibson P, Buttcrworth L, Cooksley W, et al. The C282Y mutation in HFE is common in Australian patients and can interact independently of HCV to precipitate porphyria cutanea tarda (abstract). Hepatology 1997;26:606A.
100. Hift R, Corrigal A, Meissner P, Kirsch R. Significance of HLA mutations in South Africa patients with porphyria cutanea tarda (abstract). Acta Haematol 1997;98:112A.
101. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998;27:181-4.
102. Yaouanq J, Grosbois B, Jouanolle A, Goasguen J, Leblay R. Haemochromatosis Cys282Tyr mutation in pyridoxine-responsive sideroblastic anaemia. Lancet 1997;349:1475-6.
103. Mohler D, Wheby M. Case report. Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis. Am J Med Sci 1986;29:320-4.